219 related articles for article (PubMed ID: 32849622)
1. Tracking the Trajectory of Functional Humoral Immune Responses Following Acute HIV Infection.
Jennewein MF; Mabuka J; Papia CL; Boudreau CM; Dong KL; Ackerman ME; Ndung'u T; Alter G
Front Immunol; 2020; 11():1744. PubMed ID: 32849622
[TBL] [Abstract][Full Text] [Related]
2. Topical Tenofovir Pre-exposure Prophylaxis and Mucosal HIV-Specific Fc-Mediated Antibody Activities in Women.
Fisher KL; Mabuka JM; Sivro A; Ngcapu S; Passmore JS; Osman F; Ndlovu B; Abdool Karim Q; Abdool Karim SS; Chung AW; Baxter C; Archary D
Front Immunol; 2020; 11():1274. PubMed ID: 32733445
[TBL] [Abstract][Full Text] [Related]
3. Viral control in chronic HIV-1 subtype C infection is associated with enrichment of p24 IgG1 with Fc effector activity.
Chung AW; Mabuka JM; Ndlovu B; Licht A; Robinson H; Ramlakhan Y; Ghebremichael M; Reddy T; Goulder PJR; Walker BD; Ndung'u T; Alter G
AIDS; 2018 Jun; 32(10):1207-1217. PubMed ID: 29620716
[TBL] [Abstract][Full Text] [Related]
4. Evidence for a defect of antibody-dependent cellular cytotoxic (ADCC) effector function and anti-HIV gp120/41-specific ADCC-mediating antibody titres in HIV-infected individuals.
Ahmad A; Morisset R; Thomas R; Menezes J
J Acquir Immune Defic Syndr (1988); 1994 May; 7(5):428-37. PubMed ID: 7908983
[TBL] [Abstract][Full Text] [Related]
5. IgG subclass profiles in infected HIV type 1 controllers and chronic progressors and in uninfected recipients of Env vaccines.
Banerjee K; Klasse PJ; Sanders RW; Pereyra F; Michael E; Lu M; Walker BD; Moore JP
AIDS Res Hum Retroviruses; 2010 Apr; 26(4):445-58. PubMed ID: 20377426
[TBL] [Abstract][Full Text] [Related]
6. [Blood antigens and specific anti-core and anti-envelope antibodies as markers of the course of HIV infection].
Sorice F; Vullo V; Cirelli A; Catania S; Mastroianni CM; Contini C; Delia S
Boll Ist Sieroter Milan; 1989; 68(2):115-21. PubMed ID: 2562362
[TBL] [Abstract][Full Text] [Related]
7. Antibody from patients with acute human immunodeficiency virus (HIV) infection inhibits primary strains of HIV type 1 in the presence of natural-killer effector cells.
Forthal DN; Landucci G; Daar ES
J Virol; 2001 Aug; 75(15):6953-61. PubMed ID: 11435575
[TBL] [Abstract][Full Text] [Related]
8. Antigen-Specific Antibody Glycosylation Is Regulated via Vaccination.
Mahan AE; Jennewein MF; Suscovich T; Dionne K; Tedesco J; Chung AW; Streeck H; Pau M; Schuitemaker H; Francis D; Fast P; Laufer D; Walker BD; Baden L; Barouch DH; Alter G
PLoS Pathog; 2016 Mar; 12(3):e1005456. PubMed ID: 26982805
[TBL] [Abstract][Full Text] [Related]
9. In vitro antibody production (IVAP) in the follow-up of pediatric human immunodeficiency virus type 1-infected patients.
Rusconi S; Riva A; Cocchi F; Massironi E; Tornaghi R; de Maddalena C; de Pasquale MP; Galli M
Pediatr AIDS HIV Infect; 1997 Apr; 8(2):127-9. PubMed ID: 11361779
[No Abstract] [Full Text] [Related]
10. Humoral immunity to HIV-1: kinetics of antibody responses in chronic infection reflects capacity of immune system to improve viral set point.
Trkola A; Kuster H; Leemann C; Oxenius A; Fagard C; Furrer H; Battegay M; Vernazza P; Bernasconi E; Weber R; Hirschel B; Bonhoeffer S; Günthard HF;
Blood; 2004 Sep; 104(6):1784-92. PubMed ID: 15187026
[TBL] [Abstract][Full Text] [Related]
11. Correlation of Antibody Responses to a Peptide Antigen gp120-C5
Sørensen B; Sommerfelt MA; Stjernholm G; Smith PL; Ökvist M; Hovden AO; Hoddevik G; Redfield R; Ustina V; Jelmert Ø; Zeldis J; Dalgleish A
AIDS Res Hum Retroviruses; 2017 Jun; 33(6):558-566. PubMed ID: 28051320
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal Antibodies Specific for the V2, V3, CD4-Binding Site, and gp41 of HIV-1 Mediate Phagocytosis in a Dose-Dependent Manner.
Musich T; Li L; Liu L; Zolla-Pazner S; Robert-Guroff M; Gorny MK
J Virol; 2017 Apr; 91(8):. PubMed ID: 28122974
[TBL] [Abstract][Full Text] [Related]
13. Defective killing activity against gp120/41-expressing human erythroleukaemic K562 cell line by monocytes and natural killer cells from HIV-infected individuals.
Ahmad A; Menezes J
AIDS; 1996 Feb; 10(2):143-9. PubMed ID: 8838701
[TBL] [Abstract][Full Text] [Related]
14. Bridging Vaccine-Induced HIV-1 Neutralizing and Effector Antibody Responses in Rabbit and Rhesus Macaque Animal Models.
Pollara J; Jones DI; Huffman T; Edwards RW; Dennis M; Li SH; Jha S; Goodman D; Kumar A; LaBranche CC; Montefiori DC; Fouda GG; Hope TJ; Tomaras GD; Staats HF; Ferrari G; Permar SR
J Virol; 2019 May; 93(10):. PubMed ID: 30842326
[TBL] [Abstract][Full Text] [Related]
15. Positive correlation between the natural killer and gp 120/41-specific antibody-dependent cellular cytotoxic effector functions in HIV-infected individuals.
Ahmad A; Menezes J
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Oct; 10(2):115-9. PubMed ID: 7552474
[TBL] [Abstract][Full Text] [Related]
16. Polyfunctional HIV-Specific Antibody Responses Are Associated with Spontaneous HIV Control.
Ackerman ME; Mikhailova A; Brown EP; Dowell KG; Walker BD; Bailey-Kellogg C; Suscovich TJ; Alter G
PLoS Pathog; 2016 Jan; 12(1):e1005315. PubMed ID: 26745376
[TBL] [Abstract][Full Text] [Related]
17. Antibody responses to HIV-1 envelope and gag epitopes in HIV-1 seroconverters with rapid versus slow disease progression.
Zwart G; van der Hoek L; Valk M; Cornelissen MT; Baan E; Dekker J; Koot M; Kuiken CL; Goudsmit J
Virology; 1994 Jun; 201(2):285-93. PubMed ID: 7514319
[TBL] [Abstract][Full Text] [Related]
18. Differential maturation of avidity of IgG antibodies to gp41, p24 and p17 following infection with HIV-1.
Thomas HI; Wilson S; O'Toole CM; Lister CM; Saeed AM; Watkins RP; Morgan-Capner P
Clin Exp Immunol; 1996 Feb; 103(2):185-91. PubMed ID: 8565298
[TBL] [Abstract][Full Text] [Related]
19. Dynamic antibody specificities and virion concentrations in circulating immune complexes in acute to chronic HIV-1 infection.
Liu P; Overman RG; Yates NL; Alam SM; Vandergrift N; Chen Y; Graw F; Freel SA; Kappes JC; Ochsenbauer C; Montefiori DC; Gao F; Perelson AS; Cohen MS; Haynes BF; Tomaras GD
J Virol; 2011 Nov; 85(21):11196-207. PubMed ID: 21865397
[TBL] [Abstract][Full Text] [Related]
20. Human immunodeficiency virus type-1 (HIV-1) evades antibody-dependent phagocytosis.
Gach JS; Bouzin M; Wong MP; Chromikova V; Gorlani A; Yu KT; Sharma B; Gratton E; Forthal DN
PLoS Pathog; 2017 Dec; 13(12):e1006793. PubMed ID: 29281723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
